Home Healthcare

Healthcare

Impact focus – Solutions that remimagine access and affordability of healthcare

Your Apple Watch may soon be able to save your life. The devices used for everything from messaging friends to shopping may also be able to curb stroke risk by detecting atrial fibrillation —...
A Chinese app that lets users check their proximity to people infected with coronavirus may be poised to backfire because it’s unreliable and may stigmatize patients, a report says. The app launched last week...
Robot technology has found a new use: steadying the hands of surgeons and permitting previously impossible operations. Doctors in the Maastricht University Medical Center in the Netherlands used a new robot for the first...
The gene-editing technique known as CRISPR was declared safe and feasible after a trial in cancer patients, potentially opening the door for the controversial tool’s wider use in fighting disease and improving health.The clinical trial, with just...
Babylon Health, whose chatbot app is already disrupting the U.K.’s National Health Service, is aiming for perhaps a greater revolution: supercharging medical diagnoses with an algorithm that analyzes vast, unconnected databases for causes and effects.The technique distinguishes...
Andreessen Horowitz, the Silicon Valley PE firm that bet on Twitter, Skype and BuzzFeed, is boosting wagers on another industry being transformed by software: healthcare. The firm, with $10 billion in assets under management,...
A drug developed using artificial intelligence will enter clinical trials for the first time, opening up the possibility of using machine learning to slash costs and time needed to create medicines. The compound targeting...
The novel coronavirus that is spreading in China may harm the health of more than those who catch the respiratory illness — the killer infection may disrupt production of the world’s pharmaceuticals.China is a giant supplier of...
With more than 500,000 people dying each year due to their bodies rejecting currently available antibiotics, profits are drying up and the world’s largest drugmakers are backing off. This is leaving the field to a group of...
Sam sends a message to his friend every morning asking how she feels that day, followed by a smiley emoji. He reminds her to take good care of herself and encourages her to be positive. 
Frazier Healthcare raised a greater-than-expected $617 million for its latest fund, as private investors’ appetite for healthcare innovation shows no sign of slowing. Frazier Life Sciences X, the company’s third life sciences fund, is slated...
Once thought manageable, heart disease is making a dangerous comeback in the U.S., killing more than ever with a surprising toll on city dwellers. While doctors cite increasing stress and spreading sedentary lifestyles, private...
Sex tech was back at the annual Consumer Electronic Show, with the focus on more polite theme of “wellness,” and less on sex toys. The wellness technology goes beyond vibrators to tools intended to...
Drugmakers are finding themselves getting into mining these days. And venture capital is taking notice. Pharmaceutical companies have started to replace parts of clinical trials with mining medical records to speed drug approval, with...
Fracking, assailed for its environmental cost while its made the U.S. the world’s top oil producer, is being investigated as a possible cause in the surge of young people hit by a rare cancer in Pennsylvania.Pennsylvania is...
It’s the world’s most expensive drug, and one of only two available for spinal muscular atrophy, the top genetic killer of children under two years old. And now the drug’s maker, Novartis, wants to give it away...
It may be the final frontier in medicine -- slowing down or reversing the process of aging. Besides the promise of a longer life, it also means fortunes made -- think Ponce de Leon and his search...
Purdue Pharma, facing fines of $12 billion for fueling the opioid crisis in the U.S., has a foreign affiliate peddling a surprising medication -- an antidote for opioid overdose. And now the Australian affiliate...
Magic mushrooms as a treatment for depression took another step toward mainstream acceptance as a venture capital-backed company announced positive results from a psilocybin trial. Compass Pathways’ psilocybin medication was “well-tolerated in healthy volunteers,”...
Private equity and venture capital firms, which have poured billions of dollars in biotech firms, are opposing House Speaker Nancy Pelosi’s plan to cut drug prices, saying it would stifle the small firms that are often the...
Magic Leap, in the midst of a pivot after its much-hyped entertainment headset failed to catch on, debuted a new version of its augmented-reality equipment that’s designed for a new crowd -- businesses including healthcare.The Magic Leap...
Key Takeaway: Even though his research opens up a variety of ethical issues and has received funding from donors like sex offender Jeffrey Epstein, geneticist George Church...
Magnetar Capital, which has made billions on its energy and infrastructure bets, is joining others who are seeing green lights flashing in healthcare. The $13.4 billion hedge fund is seeking to raise $400 million,...
Amazon’s latest step in using technology to make healthcare more effective is simple: A voice-technology service that enables medical providers to spend more time with patients.The service, called Amazon Transcribe Medical, enables doctors to quickly dictate their...
A year after a Chinese scientist unleashed a storm of condemnation by announcing the birth of a baby whose genes he had edited, the medical and scientific community has yet to agree on rules guiding research into...
Stem cell biotech company Novoheart and pharmaceutical giant AstraZeneca announced they would be partnering to develop the first test tube model of human heart failure, also called heart-in-a-jar. The companies said they would use...
Mark Zuckerberg, Facebook’s embattled co-founder and CEO, isn’t just interested in creating the biggest ad machine and political platform in history. He also wants to fix and accelerate the rate of scientific discovery. In...
Blackstone, which last year started up a life sciences investing arm, is pouring $400 million into a venture with a Swiss pharmaceutical firm to develop and commercialize a gene therapy for bladder cancer. Blackstone’s...
A recent number of studies and funding rounds offered a glimpse into what the new wave of quantum biology research may offer and how the new generation of innovative solutions may take shape. Mursla,...
Medicare may not be getting the best prescription drug deals it can, meaning senior citizens using the plan are overpaying, a new study suggests. Private insurance companies adopt cheaper generic drugs at a faster...
- Advertisement -